TrialThe oncologist2021

Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study.

Caroline A Nebhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.